GENE FOR INSECTICIDAL PROTEIN

Abstract: A DNA fragment comprising a nucleotide sequence coding for an insecticidal protein having an amino acid sequence substantially the same as all or a part of an amino acid sequence of an insecticidal crystal protein derived from Bacillus thuringiensis; plasmid containing the DNA frag­ ment; and E. coli transformed with the plasmid.

Description: BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to genes coding for insecticidal proteins, plasmids containing the genes, and microorganisms transformed with the plasmids. 2. Description of the Related Art Since an insecticidal protein produced by Bacillus thuringiensis shows toxicity against larvae of Lepidoptera, preparations containing the insecticidal protein have been commercially provided as insecticides with selective toxicity to insects. As the insecticidal protein, however, is produced only during the sporulation period, by Bacillus thuringiensis, the production period is rather short, and this limits the productivity of the protein. Therefore, the microbial insecticide is higher in cost than conventional chemically synthesized insecticides. Moreover, the insecticidal protein produced by Bacillus thuringiensis is characteristically crystalline, and has a poor solubility in water. Accordingly, it is difficult to economically separate and purify the protein from the spores of producer cells. Therefore, the conventional microbial insecticides are prepared as formulations containing spores of Bacillus thuringiensis, which spores will pollute the environment when the formulation is used. To overcome the drawbacks of the conventional microbial insecticides, approaches involving gene recombination techniques have been proposed. Namely, Wong et. al. J. Biol. Chem. 258, 1960 (1983) describes a part of a nucleotide sequence of an amino-terminal of insecticidal protein of Bacillus thuringiensis subsp. Kurstaki HD-I-Dipel origin. However, the nucleotide sequence is different from that of the present invention at three sites, which provides the difference of three amino acid residues in the protein. JP-A-58-500565 (equivalent to EP-A-63949 and WO 82/03872), refers to a DNA fragment coding for an insecticidal protein of Bacillus thuringiensis subsp. sotto origin, but does not include a detailed description thereof. Moreover, the molecular weights of a plasmid included in the Bacillus thuringiensis subsp. sotto, and of the produced insecticidal protein, are different from those of the present invention. SUMMARY OF THE INVENTION Therefore, as a means for production of a protein which has a insecticidal activity equivalent to that produced by Bacillus thuringiensis, is soluble in water, and can be produced over a long period when culturing a producer microorganism, it is sought to provide gene systems coding for the above-mentioned protein. In one aspect the invention provides a DNA fragment comprising a nucleotide sequence coding for an insecticidal protein having an amino acid sequence as set out in Fig. 1, or having an amino acid sequence comprising at least 723 amino acids from the N-terminus thereof. In a second aspect the invention provides a DNA fragment having the nucleotide sequence from position 153 to position 3692 (codons 1 to 1180) as set out in Fig. 1, or at least 723 codons from the 5'-terminus of that sequence. In a third aspect the invention provides a plasmid capable of replicating in E. coli and expressing the insecticidal protein defined above, comprising a pBR322 plasmid in which a DNA sequence as defined has been inserted. In a fourth aspect the invention provides E. coli transformed with the plasmid so as to produce insecticidal protein. In a fifth aspect the invention provides water-soluble insecticidal protein produced by an organism transformed with said DNA. In further aspects the invention provides processes comprising the production of the DNA fragments, plasmids and proteins described. BRIEF DESCRIPTION OF THE DRAWINGS Figures 1-1 to 1-10 represent a nucleotide sequence of a 5 kilo base (kb) insert of DNA fragment in plasmid pSP801 including an open reading frame, and an amino acid sequence deduced from a nucleotide sequence corresponding to the open reading frame. Figure 2 represents a restriction map of a starting plasmid pSY1 derived from Bacillus thuringiensis subsp. sotto. Figure 3 represents a flow chart of the construction of plasmids according to the present invention. Figure 4 represents a restriction map of plasmid pSP801. Figure 5 schematically represents a principle for determination of a region coding for an insecticidal protein in 6.6 kb insert of DNA fragment in the plasmid pSP801. Figure 6 represents a restriction map of 2.95 kb insert of DNA fragment in plasmid pLBT291. Figure 7 is a photograph of electrophoresis showing expression of insecticidal protein by plasmid pLBT291 (lane 1) , pKB5 (lane 2), pKA2 (lane 3), pMR4 (lane 4), pHP1 (lane 5), pSP801 (lane 6), pSX8 (lane 7), and pBR322 (lane 8, control). DESCRIPTION OF THE PREFERRED EMBODIMENT The DNA fragment coding for an insecticidal protein according to the present invention is derived from a plasmid pSY1 present in Bacillus thuringiensis subsp. sotto and including a gene for insecticidal protein. The plasmid pSY1 is isolated from the above-mentioned strain according to a modification of the method described by Hansen and Olsen, J. Bacteriol. 135, 227-238 (1978) . The molecular size of the plasmid is calculated to be 68 kb. As shown in Fig. 3, the plasmid pSY1 is cleaved with a restriction enzyme XhoI to obtain a DNA fragment containing a gene coding for insecticidal protein. The DNA fragment is then inserted into an XhoI site of a cloning vector pKAT 1 The ligation mixture is used to transform E. coli C600, and the transformants are screened for ampicillin resistance and the production of insecticidal proteins as determined by radioimmunoassay to obtain a clone containing plasmid pSX8, which includes an 18 kb insert containing a nucleotide sequence coding for the insecticidal protein. The plasmid pSX8 is cleaved with various kinds of restriction enzymes, and each of the DNA fragments thus obtained is ligated to a cloning vector pBR322 cleaved with the corresponding restriction enzyme. Each of the ligation mixtures is used to transform E. coli HB101, and the transformants are screened as described above to obtain a clone E. coli HB101/pSP801, which contains a plasmid pSP801 of about 11.0 kb including a 6.6 kb PstI DNA insert. A restriction map of the plasmid pSP801 is represented in Fig. 4. As E. coli HB101/pSP801 produces a polypeptide having a molecular weight of about 144 kilo Daltons (kD), and this molecular weight is approximately the same as that of a crystal protein produced by Bacillus thuringiensis, the insert of about 6.6 kb in the plasmid pSP801 is supposed to contain a nucleotide sequence coding for the entire amino acid sequence of a protein, the same as the crystal protein produced by Bacillus thuringiensis. The plasmid pSP801 is then cleaved with restriction enzymes M1uI and HpaI to obtain a DNA fragment of about 2.95 kb, which is then filled-in, and added with Bam HI linker at both terminals. The DNA fragment thus modified is then inserted into a Bam HI site of pBR322 to obtain a ligation mixture. The mixture is used to transform E. coli HB101, and the transformants are screened as described above to obtain a clone E. coli HB101/pLBT291. The clone E. coli HB101/pLBT291 produces a polypeptide of about 75 kD having insecticidal activity. Therefore, the above-mentioned DNA fragment of about 2.95 kb is confirmed to contain a nucleotide sequence coding for a part of the amino acid sequence of the insecticidal crystal protein produced by Bacillus thuringiensis. A nucleotide sequence of the DNA fragment of about 2.95 kb corresponds to a nucleotide sequence at positions 1 to 2955 in Fig. 1-1 to 1-7. The DNA fragment consists of 2955 bases, in which 2802 bases from the positions 153 to 2954 encode 934 amino acids corresponding to the above-mentioned polypeptide. Another part of the DNA fragment consisting of nucleotides from the positions 1 to 152 is a 5' non-coding sequence. The nucleotide sequence is different from the nucleotide sequence disclosed by Wong et. al., supra , at three sites, which difference results in a difference of three amino acids in the peptide. Examples The present invention will now be further illustrated by, but is no means limited to, the following examples. (1) Preparation of plasmid pSY1 Plasmid pSY1 was prepared from Bacillus thuringiensis subsp. sotto according to a modification of the alkali-method described by Hansen and Olsen, J. Bacteriol. 135, 227-238 (1978). The above-mentioned bacterium was cultured in 400 ml of Penassay broth, and the cultured cells were suspended in 10.8 ml of a solution comprised of 25% sucrose, 50 mM Tris-HCl, and 20 mM EDTA (pH 8.0), and the suspension was added with 10 mg/ml of lisozyme and incubated at 37°C for one hour. The suspension was then added with pronase E (T.M) and sodium dodecyl sulfate (SDS) to concentrations of 0.5 mg/ml and 1% respectively, and incubated at the same temperature for another one hour to lyse the cells completely. The lysate was added with 3 ml of 3N NaOH and incubated at a room temperature for three minutes, and then added with 8 ml of 2M Tris-HCl (pH 7.0), 4 ml of 20% SDS, 8 ml of 5M NaCl, and incubated for six hours in ice. The thus-treated lysate was centrifuged at 17,000 x G for 30 minutes to obtain a supernatant. To the supernatant, polyethylene glycol 6000 was added to a concentration of 10% to precipitate DNA. DNA was dissolved in 20 ml of a solution comprised of 20 mM Tris-HCl, 5 mM EDTA and 150 mM NaCl (ph 7.5), and the solution was added with RNase A to a concentration of 0.1 mg/ml, incubated at 37°C for two hours, extracted with phenol, and added with two volumes of ethanol to precipitate DNA. The precipitate was dissolved in 5 ml of a solution comprising 20 mM Tris-HCl, 5 mM EDTA, and 150 mM NaCl (pH 7.5), and the solution was passed through a Biogel A-0.5 m (T.M.) column, and a void volume fraction was recovered. To this fraction, ethanol was added to precipitate DNA, which was then purified by density-equilibrium centrifugation in ethidium bromide-cesium chloride. The plasmid DNA thus obtained showed a single band under agarose gel electrophoresis. (2) Restriction map of plasmid pSY1 DNA of plasmid pSY1 was treated with restriction enzymes. The DNA was cleaved with Bam HI and Stu I at one site, with Bgl II and Xho I at three sites, and with Mlu I and Sac I at four sites, but not cleaved with Aat II, Sal I and Sma I. Bon I, Bcl II, Cla I, Eco RI, Hind III, Hpa I, Kpn I, Pst I and Pvu II provided many fragments. Figure 2 represents a restriction map obtained by Bgl II and Xho I. Cleavage sites of Bam HI and Stu I locate on a Bgl II-A fragment and an Xho I-A fragment, respectively, at a distance of about 2 kb. On the basis of the size of DNA fragments, the plasmid pSYl was found to be 68 kb in size. (3) Selection of Transformant by Radioimmunoassay In the plasmid construction described below, E. coli transformed with a plasmid containing a gene for an insecticidal protein were selected according to a modification of the procedure described by Erlich et. al., Cell, 13 , 681-689 (1978) using an antibody against the insecticidal protein. Bacillus thuringiensis subsp. sotto was cultured in a modified G medium described by Aronson et. al., J. Bacteriol. 106, 1016-1025 (1971) for three days, and the insecticidal crystal protein was isolated and purified from the culture according to a method of Sharpe et. al., Appl. Microbiol. 30, 1052-1053 (1975). The purified protein was used as an antigen to prepare the antibody. The antibody IgG thus obtained was labeled with 125 I according to a procedure described by Marrison and Bayse, Biochemistry 9 , 2995-3000 (1970). Cells of E. coli to be tested were cultured on an agar plate medium to form colonies, and the agar plate carrying the colonies thereon was exposed to vapor of chloroform for 30 minutes, and overlaid with an agar layer containing 1 mg/ml lysozyme, 10 mM EDTA and 0.02% Triton X100 (T.M) to lyse cells of the colonies. On the overlaid agar plate was placed a DBM filter paper on which the unlabeled antibody had been bonded according to a procedure described by Alwine et. al., Proc. Natl. Acad. Sci. USA, 74, 5350-5354 (1977), and allowed to stand for 12 to 15 hours. The filter paper was washed with 10 mM phosphate buffer pH 7.2 containing 5% bovine serum and 0.15M NaCl (CS-PBS), and maintained in 10 mN Tris-HCl buffer pH 7.5 containing 0.14M NaCl, 25% bovine serum and 4 x 10⁶ cpm ¹²⁵I-labeled antibody prepared as described above for 5 to 7 hours. The filter was then washed with CS-PBS, dried, and exposed on an X-ray film to carry out autoradiography. (4) Construction of plasmid pSX8 The route for the construction of plasmid pSX8 is shown in Fig. 3. The plasmid pSY1 was cleaved with a restriction enzyme XhoI to obtain DNA fragments. A cloning vector plasmid pKAT1 was cleaved with Xho I. The DNA fragments from pSY1 were then inserted to Xho I site of the cleaved pKAT1 with T4 DNA ligase to obtain a ligation mixture, which was then used to transform cells of E. coli C600. The transformants were first screened on L broth agar plate medium supplemented with 25 µg/ml ampicillin to select clones resistant to ampicillin, the selected clones were then subjected to the radioimmunoassay described in paragraph (3), and a positive clone containing recombinant plasmid pSX8 was selected. The plasmid pSX8 contains a 18 kb insert of DNA fragment, which includes a gene coding for an insecticidal protein. (5) Construction of plasmid pSP801 The plasmid pSX8 was cleaved with a restriction enzyme Hind III, Pst I, or Eco RI to obtain DNA fragments, which were then inserted into a corresponding restriction site of cloning vectors pBR322 and pBR325 cleaved with the corresponding restriction enzyme, and each ligation mixture was used to transform E. coli HB101. The transformants thus obtained were then screened according to the above-described procedures to select a clone expressing an insecticidal protein. As a result, from the ligation of Pst I - cleaved pSX8 DNA fragment with Pst I - cleaved pBR322 fragment, a clone E. coli HB101/pSP801 containing plasmid pSP801 was selected. The route for construction of the plasmid pSP801 is shown in Fig. 3, and a restriction map of the plasmid pSP801 is shown in Fig. 4. The plasmid pSP801 contains an inserted Pst I DNA fragment of 6.6 kb, which includes a gene coding for an insecticidal protein. (6) Construction of plasmid pLBT291 As shown in Fig. 3, plasmid pSP801 was cleaved with Mlu I and Hpa I, and the Mlu I - HPa I DNA fragment thus obtained was filled-in, and attached with Bam HI linkers at both terminals. The Bam HI fragment was then inserted into a Bam HI site of pBR322. The ligation mixture thus prepared was used to transform E. coli HB101. The transformants were then screened according to the radioimmunoassay described in paragraph (3) to obtain a clone E. coli HB101/pLBT291, containing plasmid pLBT291. It was confirmed that the clone produced an insecticidal protein, by the bioassay described below in detail in paragraph (9). The plasmid pLBT291 contained a 2.95 kb insert of DNA fragment which corresponds to the Hpa I·2 - Mlu I fragment on plasmid pSP801. (7) Determination of location of gene coding for insecticidal protein To determine a location of gene coding for an insecticidal protein on the 6.6-kb insert of pSP801, deletion derivatives were constructed from pSP801 using the restriction sites indicated in Fig. 5. Each of these derivatives was used to transform E. coli HB101, and a clone containing plasmid pHP1, pMR4, pKA2, pKB5, or pKB53 was obtained. Among these plasmids, as shown in Fig. 5, plasmid pMR4 contained all regions of the 6.6 kb-PstI DNA fragment and 4 base pairs insertion at the Mlu I site, but other plasmids contained only parts of the PstI DNA fragment. Each of the clones was cultured, and tested for the production of an insecticidal protein by the radioimmunoassay described in paragraph (3) and bioassay described below in paragraph (9). The results obtained from the above-mentioned tests are summarized in Fig. 5, together with the result obtained from pSP801 and pLBT291. In Fig. 5, the left part of the drawing represents profiles of a region of each plasmid corresponding to the 6.6-kb Pst I DNA fragment in plasmid pSP801. The right side columns represent the results of the radioimmunoassay and bioassay respectively, wherein + denotes positive, - denotes negative, and + denotes intermediate activity. From, Fig. 5, it is confirmed that the gene coding for an aimed insecticidal protein is located on the 2.95 kb Hpa I·2 - Mlu I fragment in pSP801. This was confirmed by a direct cloning of the 2.95 Hpa I·2 - Mlu I fragment into the Bam HI site of pBR322 using a Bam HI linker. The resulting plasmid pLBT291 was positive in both the radioimmunoassay and bioassay. (8) Electrophoretic analysis of gene products produced in E. coli cells The clones which were pronounced positive in the radioimmunoassay, i.e., E. coli HB101/pSX8, E. coli HB101/pS801, E. coli HB101/pLBT291, and other clones containing pKB5, pKA2, pMR4 and pHP1 respectively, as well as the control clone, i.e., E. coli HB101/pBR322, were cultured in 400 ml of L-broth medium supplemented with 25 µg/ml of ampicillin, overnight at 37°C, and the cultured cells were collected by centrifugation and suspended in a buffer solution containing 150 mM NaCl, 20 mM Tris-HCl (pH8.0), 5 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, and 7 mM mercaptoethanol. The suspension was added with 0.3 ml of 10 mg/ml lysozyme, maintained on ice for 30 minutes, and sonicated for three minutes to rupture the cells. The sonicated product was then centrifuged at 14,000 xg for 20 minutes to recover a supernatant. The supernatant was then dialysed overnight in 20 mM phosphate buffer pH7.2. The extracts thus obtained from the cultured E. coli were subjected to electrophoresis and bioassay. In the electrophoresis, the extracts were separated on 7% SDS-polyacrylamide gel according to a conventional procedure. The separated products were electrophoretically transferred to a nitrocellulose filter, and the nitrocellulose filter was incubated successively with an antibody against the insecticidal crystalline protein, anti-rabbit IgG antibody labeled with peroxidase, and then with a substrate solution for the peroxidase. In this manner, only polypeptides having reactivity with the antibody against the insecticidal protein bind the antibody, which in turn binds the anti-rabbit IgG labeled with peroxidase, which acts on its substrate to develop color showing the presence of the aimed polypeptide on the nitrocellulose filter. The electrophoresis patterns are shown in Fig. 7, wherein lane 1 represents a product from a clone containing plasmid pLBT291, lane 2 represents that from pKB5, lane 3 represents that from pKA2, lane 4 represents that from pMR4, lane 5 represents that from pHP1, lane 6 represents that from pSP801, lane 7 represents that from pSX8, and lane 8 represents that from pBR322. Although the insecticidal protein produced by Bacillus thuringiensis has been known to comprise three polypeptides, i.e., a main polypeptide having a molecular weight of 144 kD, and two minor polypeptides having a molecular weight of 97 kD and 76 kD respectively, the plasmids pMR4 (lane 4), pHP1 (lane 5), pSP801 (lane 6), and pSX8 (lane 7) provided a band corresponding to 144 kD, which corresponded to the main polypeptide of the insecticidal protein produced by Bacillus thuringiensis. On the other hand, plasmid pLBT291 provided a band corresponding to 75 kD. Plasmids pKB5 and pKA3, which were not pronounced positive in the radioimmunoassay and bioassay, and the control plasmid pBR322, provided no clear bands. The above-mentioned result shows that the Pst I fragment in pSP801 and in pMR4, and the Hpa I.2 - Pst I fragment in pHP1 contain a DNA sequence coding for a full length polypeptide of 144 kD. On the other hand, since the Hpa I.2 - Mlu I fragment of 2.95 kb in pLBT291 corresponds to a 5'-terminal side part of the Hpa I.2 - Pst I fragment in pHP1, the Hpa I.2 - Mlu I 2.95 kb fragment in pLBT291 should encode a polypeptide corresponding to a part of the 144 kD polypeptide. In this connection, it should be noted that both the 75 kD polypeptide derived from pLBT291 and the 144 kD polypeptide derived from other plasmids react with the antibody against the insecticidal protein obtained from Bacillus thurringiensis. This suggests that the 75 kD polypeptide contains an essential region or site for the insecticidal activity. (9) Bioassay for insecticidal activity of gene product from transformed E. coli The extracts prepared as described in paragraph (8) from E. coli HB101/pBR322, E. coli HB101/pSX8, E. coli HB101/pSP801, and E. coli HB101/pLBT291 were tested for their insecticidal activity. 1 ml of each extract was impregnated into 10 g of an artificial feed composition for silkworms, and the impregnated feed composition was put in a plastic container, into which five fifth instar silkworms were incorporated. The container was allowed to stand overnight, and the viability rate and an amount of increase of the body weight of the silkworms were determined. The results are set forth in the following table. As seen from the table, all of the silkworms which ate the feed impregnated with the extract prepared from E. coli transformed with pSX8, pSP801 or pLBT291 died, and a significant increase of weight was not observed. On the other hand, all of the silkworms which ate the feed impregnated with phosphate buffer solution or with the extract derived from plasmid pBR322 were viable and a substantial increase of body weight was observed. It should be noted that the 75 kD polypeptide expressed by pLBT291 shows an insecticidal activity substantially identical to that of the 144 kD polypeptide which corresponds to the main polypeptide of the insecticidal crystal protein produced by Bacillus thuringiensis. This means that the 75 kD polypeptide contains a site or region essential for the insecticidal activity. Moreover, it should be noted that, in contrast with the natural insecticidal crystal protein produced by Bacillus thuringiensis, which is almost insoluble in water, both the 144 kD polypeptide and 75 kD polypeptide expressed by genes of the present invention are soluble in water. (10) Determination of nucleotide sequence of DNA fragment containing gene coding for insecticidal protein The sequence of the Hpa I.2 - Mlu I DNA fragment of 2.95 kb in plasmid pSP801, corresponding to the Bam HI DNA fragment of 2.95 bp in plasmid pLBT291 was determined according to the dideoxy method described by Messing, Method in Enzymology Vol. 101C, 20-78. A detailed restriction map of the Hpa I.2 - Mlu I fragment is set forth in Fig. 6. The 2.95 kb DNA fragment was cleaved with restriction enzymes Sau 3A, Hpa II, and Taq I, and the resulting DNA fragments were cloned into phage M13mp10, or M13mp11. Moreover, the 2.95 kb DNA fragment was cleaved with restriction enzymes Cla I, Hind III, and Eco RI, and the resulting DNA fragments were cloned into phage M13mp10 or M13mp11. These cloned minute DNA fragments were sequenced according to the above-cited Messing's method, and the determined sequences were overlapped to determine a whole nucleotide sequence of the 2.95 kb DNA fragment. Moreover, the Mlu I - Pst I DNA fragment of 2 kb positioned adjacent to the 3'-terminal of the Hpa I.2 - Mlu I 2.95 kb fragment was sequenced as above-mentioned. In this manner, finally, the whole nucleotide sequence of the 5 kb DNA fragment from the Hpa I.2 site to the Pst I site was determined. The nucleotide sequence thus determined is set forth in Fig. 1-1 to Fig. 1-10. The 5 kb DNA fragment consists of 5,002 bp, and contains a single large open reading frame starting from a starting codon ATG, wherein base "A" corresponds to the position 153 in the sequence in Fig. 1-1, and terminating at a stop codon TAA, wherein the last base "A" corresponds to the position 3,695 in the sequence in Fig. 1-8. The open reading frame consists of 3,540 bp, and is flanked by a 5'-non-translation sequence consisting of 152 bp, and by a 3'-flanking sequence consisting of 1,310 bp. There is no other open reading frame corresponding to the molecular weight of the insecticidal protein. Therefore the 144 kD insecticidal polypeptide should be derived from the above-mentioned open reading frame. The open reading frame consisting of 3,540 bp encodes 1180 amino acids. Therefore, the 144 kD insecticidal polypeptide is assumed to consist of 1180 amino acid residues starting from Met at the amino acid position 1 and terminating by Glu at the amino acid position 1180, which corresponds to 133,481 Dalton of the molecular weight. This amino acid sequence reveals that approximately half at the amino terminal side of the 144 kb insecticidal polypeptide contains much less lysine and cysteine than a carboxy terminal side does. In the large open reading frame, a nucleotide sequence starting from base "A" at position 153 and terminated by "G" at the position 2954, consisting of 2802 bases, corresponds to an open reading frame contained in the 2.95 kb Hpa I.2 - Mlu I DNA fragment. The nucleotide sequence consisting of 2802 bases should encode 934 amino acids. Therefore, the polypeptide produced of E. coli transformed with plasmid pLBT291 may consist of at least 934 amino acid residues starting from Met at the amino acid position 1 to Arg at the amino acid position 934. An inverted repeat sequence capable of forming a stable stem and loop structure is found from the position 3782, which corresponds to about 100 bp downstream from the stop codon, to the position 3824, and assumed to act as a terminater on transcription. Moreover, an open reading frame reversely extending from the position 5002 to the position 4021 is found. According to the present invention, the insecticidal protein are provided in a water-soluble form. Therefore, the protein can be easily separated and purified from the producer cells. This means that insecticidal compositions specific to Lepidoptera can be produced in a form containing no producer microorganism's cells or spores. Such compositions, when used, are safe for the environment. Moreover, since E. coli transformed with the present plasmid produces the insecticidal protein without the limitation in the production period, in contrast with Bacillus thuringiensis which produces it only within the spore forming period, according to the present invention, the insecticidal protein can be produced at a lower cost. Finally, the nucleotide sequences and plasmids of the present invention can be further manipulated or modified to construct improved nucleotide sequences or plasmids which will provide new polypeptides having stronger insecticidal activity.

Claims: A DNA fragment comprising a nucleotide sequence coding for an insecticidal peptide having the following amino acid sequence: or having an amino acid sequence comprising at least 723 amino acids from the N-terminus of said amino acid sequence. A DNA fragment according to claim 1, wherein the nucleotide sequence comprises the following sequence: or a sequence comprising at least 723 codons from the 5'-terminus of said nucleotide sequence. A DNA fragment according to claim 1 or claim 2, about 6.6 kb in length. A DNA fragment according to claim 1, wherein the amino acid sequence encoded by the nucleotide sequence comprises an amino acid sequence starting from Met at the amino acid position 1 and terminating at Arg at the amino acid position 934 defined in claim 1. A DNA fragment according to claim 4, wherein the nucleotide sequence coding for the amino acid sequence comprises a nucleotide sequence starting from the position 153 and terminating at the position 2955 defined in claim 2. A DNA fragment according to any one of claims 1, 4 and 5, about 2.95 kb in length. A plasmid capable of replicating in E. coli and expressing the peptide defined in claim 1, comprising a plasmid pBR322 in which the DNA sequence defined in claim 1 has been inserted. A plasmid according to claim 7, wherein the inserted DNA fragment is about 6.6 kb in length. A plasmid according to claim 8, wherein the DNA fragment has been inserted at Pst I cleavage site in plasmid pBR322. A plasmid according to claim 7, wherein the inserted DNA fragment is about 2.95 kb in length. A plasmid according to claim 10, wherein the DNA fragment has been inserted at Bam HI cleavage site in plasmid pBR322. E. coli transformed with a plasmid according to any one of claims 7 to 11, and producing an insecticidal protein. E. coli according to claim 12, wherein the protein has a molecular weight of 144 kD. E. coli according to claim 12, wherein the protein has a molecular weight of 75 kD. An insecticidal protein which has been produced by an organism transformed so as to incorporate a DNA fragment according to any one of claims 1 to 6. A composition comprising an insecticidally effective amount of protein according to claim 15, together with a carrier. A process for making an insecticidal protein, comprising production of said protein by an organism transformed so as to incorporate a DNA fragment according to any one of claims 1 to 6. CLAIMS: [ FOR THE CONTRACTING STATE AT] A process comprising preparation of a DNA fragment comprising a nucleotide sequence coding for an insecticidal peptide having the following amino acid sequence: or having an amino acid sequence comprising at least 723 amino acids from the N-terminus of said amino acid sequence. A process according to claim 1, wherein the nucleotide sequence comprises the following sequence: or a sequence comprising at least 723 codons from the 5'-terminus of said nucleotide sequence. A process according to claim 1 or claim 2, wherein the DNA fragment is about 6.6 kb in length. A process according to claim 1, wherein the amino acid sequence encoded by the nucleotide sequence comprises an amino acid sequence starting from Met at the amino acid position 1 and terminating at Arg at the amino acid position 934 defined in claim 1. A process according to claim 4, wherein the nucleotide sequence coding for the amino acid sequence comprises a nucleotide sequence starting from the position 153 and terminating at the position 2955 defined in claim 2. A process according to claims 1, 4 and 5, where the DNA fragment is about 2.95 kb in length. A process comprising preparation of a plasmid capable of replicating in E.coli and expresing the peptide defined in claim 1, comprising insertion of a DNA sequence as defined in claim 1 in a plasmid pBR322. A process according to claim 7, wherein the inserted DNA fragment is about 6.6 kb in length. A process according to claim, 8 wherein the DNA fragment is inserted at Pst I cleavage site in the plasmid pBR322. A process according to claim 7, wherein the inserted DNA fragment is about 2.95 kb in length. A process according to claim 10, wherein the DNA fragment is inserted at Bam HI cleavage site in plasmid pBR322. E. coli transformed with a plasmid prepared in accordance with any one of claims 7 to 11, and producing an insecticidal protein. E. coli according to claim 12, wherein the protein has a molecular weight of 144 kD. E. coli according to claim 12, wherein the protein has a molecular weight of 75 kD. A process for making an insecticidal protein, comprising production of said protein by an organism transformed so as to incorporate a DNA fragment according to any one of claims 1 to 6. A process according to claim 15 wherein said organism is E. coli according to any one of claims 12, 13 and 14.

Inventors: AMACHI, TERUO C/O SUNTORY LIMITED, SHIBANO, YUJI C/O SUNTORY LIMITED, YOSHIZUMI, HAJIME C/O SUNTORY LTD.
Applicants: SUNTORY LIMITED
Application year: 1985
Main classification: C12N15
IPC codes: C12N15, C12N1, C12P21, C07K14, C12R1